Clinical Trial: Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Brief Summary: The purpose of this study is to evaluate change of cerebral glucose metabolism by donepezil therapy and to associate change of glucose metabolism and symptoms.

Detailed Summary:
Sponsor: Osaka University

Current Primary Outcome: FDG-PET [ Time Frame: 14 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Cognitive function, psychiatric symptoms, global clinical function, and burden of caregiver [ Time Frame: 14 weeks ]

Original Secondary Outcome: Same as current

Information By: Osaka University

Dates:
Date Received: October 20, 2008
Date Started: October 2008
Date Completion:
Last Updated: October 14, 2015
Last Verified: October 2015